Two best friends in Georgia were both diagnosed with cancer this year. The two boys got to ring the bell signaling the end of their cancer treatments together.

The U.S. Food and Drug Administration (FDA) has granted traditional approval to Jaypirca (pirobrutinib) for the treatment of adults with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who were previously treated with a covalent BTK inhibitor.

The Student Visionaries of the Year campaign cultivates teen leadership while advancing Blood Cancer United's mission. The Student Visionaries of the Year campaign cultivates teen leadership while advancing Blood Cancer United's mission.

The Cure keyboardist Roger O’Donnell revealed his lymphoma diagnosis in a series of posts Sunday on X in honor of September's being Blood Cancer Awareness Month. "In September last year I was diagnosed with a very rare and aggressive form of lymphoma," O ...

Blood Cancer United®, formerly The Leukemia & Lymphoma Society, announced today new scientific grants and investments to continue momentum toward cures and a better quality of life for all people with blood cancer and their families.

Non-Hodgin's Lymphoma is the seventh most common cancer in the U.S. Some forms of the disease respond well to the treatment, while others are stubborn and aggressive. Now, a new discovery may change the way doctors treat those most difficult cases.

CRANBURY, NJ, Dec. 01, 2025 (GLOBE NEWSWIRE) -- CURE® proudly announces its partnership with Blood Cancer United ®, formerly The Leukemia & Lymphoma Society®, to present the inaugural Blood Cancer Heroes ® event.